Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription Articles published in Circulation Retrieve available abstracts of 260 articles: HTML format

Single Articles

September 2025
1. GAN J, Zhao R, Zheng D, Peng Y, et al
   PYGM Protects Against Myocardial Infarction by Enhancing Glycogenolysis and Facilitating Autophagic Flux.
   Circulation. 2025 Sep 24. doi: 10.1161/CIRCULATIONAHA.124.072312.
   PubMed     Abstract available
   
   
   
2. FENG S, Wang Z, Sun R
   Letter by Feng et al Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
   Circulation. 2025;152:e239-e240.
   PubMed    
   
   
   
3. ZHONG Y, Lai R, Deng X
   Letter by Zhong et al Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
   Circulation. 2025;152:e241-e242.
   PubMed    
   
   
   
4. JI Y, Chen LY, Zhang MJ
   Response by Ji et al to Letters Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
   Circulation. 2025;152:e243-e244.
   PubMed    
   
   
   
5. LEVINE GN, Carney RM, Cohen BE, Dunn SL, et al
   Post-Myocardial Infarction Psychological Distress: A Scientific Statement From the American Heart Association.
   Circulation. 2025 Sep 22. doi: 10.1161/CIR.0000000000001381.
   PubMed     Abstract available
   
   
   
6. COUTINHO T
   The Geometry of Aging: New Angles on Cardiovascular Risk.
   Circulation. 2025;152:762-764.
   PubMed    
   
   
   
7. HUDED CP, Spertus JA, Jones PG, O'Brien SM, et al
   Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA.
   Circulation. 2025 Sep 5. doi: 10.1161/CIRCULATIONAHA.125.073591.
   PubMed     Abstract available
   
   
   
8. SHI F, Zheng B, Liu Y
   Letter by Shi et al Regarding Article "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
   Circulation. 2025;152:e71-e72.
   PubMed    
   
   
   
9. NAMBI V, de Lemos JA, Ballantyne CM
   A Proposal to Elevate the Status of Troponin and B-Type Natriuretic Peptides as Atherosclerotic Cardiovascular Disease Risk Enhancers.
   Circulation. 2025;152:567-569.
   PubMed    
   
   
   
10. KUEHN BM
    Microplastics Exposure Linked to Cardiovascular Disease Risk, Chronic Health Conditions.
    Circulation. 2025;152:630-631.
    PubMed    
    
    
    
11. SILBERNAGEL G, Wen Y, Konrad RJ
    Response by Silbernagel et al to Letters Regarding Article, "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
    Circulation. 2025;152:e73-e74.
    PubMed    
    
    
    
12. HUANG J
    Letter by Huang Regarding Article, "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
    Circulation. 2025;152:e69-e70.
    PubMed    
    
    
    
13. CROON PM, Dhingra LS, Biswas D, Oikonomou EK, et al
    Phenotypic Selectivity of Artificial Intelligence-enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction.
    Circulation. 2025 Sep 1. doi: 10.1161/CIRCULATIONAHA.125.076279.
    PubMed     Abstract available
    
    
    August 2025
14. KHAN SS, Abdalla M, Bello NA, Blyler CA, et al
    Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2025 Aug 28. doi: 10.1161/CIR.0000000000001355.
    PubMed     Abstract available
    
    
    
15. CHEN BY, Zhu H, Li YL, Zhang J, et al
    Oral Pathobionts Aggravate Myocardial Infarction Through Mobilization of B2 Cells.
    Circulation. 2025 Aug 27. doi: 10.1161/CIRCULATIONAHA.125.074837.
    PubMed     Abstract available
    
    
    
16. WU J, Zheng Y
    Letter by Wu and Zheng Regarding Article, "A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia".
    Circulation. 2025;152:e67.
    PubMed    
    
    
    
17. HO FK, Sattar N, Welsh P
    Response by Ho et al to Letter Regarding Article, "A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia".
    Circulation. 2025;152:e68.
    PubMed    
    
    
    
18. QIN D, Modanwal R, Ghazi M, Corbalan JJ, et al
    Reformulation of the Necroptosis Pathway in Reperfused Myocardial Infarction.
    Circulation. 2025;152:486-488.
    PubMed    
    
    
    
19. BERRY C, Carberry J, Dharmakumar R
    Intramyocardial Hemorrhage After Myocardial Infarction: A Prognostic Outcome for Clinical Practice and Trials.
    Circulation. 2025;152:349-351.
    PubMed    
    
    
    
20. VIDOT DC
    Up in Smoke: No Association Between Cannabis Smoking and Cardiovascular Events Among Older Military Veterans With Coronary Artery Disease.
    Circulation. 2025;152:366-368.
    PubMed    
    
    
    
21. LAWN RB, Murchland AR, Thurston RC, Marquez C, et al
    Experiences of Stalking and Obtaining a Restraining Order Are Associated With Onset of Cardiovascular Events in Women: A Prospective Analysis in the Nurses' Health Study II.
    Circulation. 2025 Aug 11:10.1161/CIRCULATIONAHA.124.073592.
    PubMed     Abstract available
    
    
    
22. STEPANIAN A, Travers RJ, Tesfu A, Wolter NL, et al
    Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke.
    Circulation. 2025 Aug 5. doi: 10.1161/CIRCULATIONAHA.125.073610.
    PubMed     Abstract available
    
    
    
23. BECKMAN JA, Drooz AT, Farber A, Hamdan A, et al
    The Impact of Coronary Artery Disease in Patients With Peripheral Artery Disease Undergoing Lower-Extremity Revascularization for Chronic Limb-Threatening Ischemia.
    Circulation. 2025;152:346-348.
    PubMed    
    
    
    
24. TABAK RG, Kandula NR, Angell SY, Brewer LC, et al
    Implementation of Evidence-Based Behavioral Interventions for Cardiovascular Disease Prevention in Community Settings: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Aug 4. doi: 10.1161/CIR.0000000000001349.
    PubMed     Abstract available
    
    
    July 2025
25. WERESKI R, Morrow DA, Mills NL
    Unstable Angina Refined.
    Circulation. 2025;152:213-216.
    PubMed    
    
    
    
26. WANG Q, Ismahil MA, Zhu Y, Rokosh G, et al
    CD206(+)IL-4Ralpha(+) Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.
    Circulation. 2025;152:257-273.
    PubMed     Abstract available
    
    
    
27. WANG J, Yang Bennett DS, Echard EJ, Chen B, et al
    Junctophilin-2 Regulates Store-Operated Calcium Entry to Drive Cardiac Fibroblast Activation, Fibrotic Repair, and Angiogenesis After Myocardial Infarction.
    Circulation. 2025 Jul 25. doi: 10.1161/CIRCULATIONAHA.125.073937.
    PubMed     Abstract available
    
    
    
28. KEYHANI S, Cohen BE, Vali M, Hoggatt KJ, et al
    Association of Smoking Cannabis With Cardiovascular Events Among Veterans With Coronary Artery Disease.
    Circulation. 2025 Jul 21. doi: 10.1161/CIRCULATIONAHA.124.073193.
    PubMed     Abstract available
    
    
    
29. CARBONNEAU M, Li Y, Qu Y, Zheng Y, et al
    DNA Methylation Signatures of Cardiovascular Health Provide Insights Into Diseases.
    Circulation. 2025 Jul 14:10.1161/CIRCULATIONAHA.124.073181.
    PubMed     Abstract available
    
    
    
30. BANN GG, Dos Santos M, Chen K, Tan W, et al
    Cellular Reprogramming by PHF7 Enhances Cardiac Function Following Myocardial Infarction.
    Circulation. 2025 Jul 9. doi: 10.1161/CIRCULATIONAHA.124.072733.
    PubMed     Abstract available
    
    
    
31. GOUPIL R, Desbiens LC, Merabtine A, Agharazii M, et al
    Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study.
    Circulation. 2025 Jul 9:10.1161/CIRCULATIONAHA.124.073507.
    PubMed     Abstract available
    
    
    
32. HU Q, Zhang J, Luo X, Hu P, et al
    Intracellular L-PGDS-Derived 15d-PGJ2 Inhibits CaMKII Through Lipoxidation to Alleviate Cardiac Ischemia/Reperfusion Injury.
    Circulation. 2025;152:41-57.
    PubMed     Abstract available
    
    
    
33. HENDREN NS, Ammirati E
    Cardiovascular Effects of COVID-19: Legacy and Future Insights.
    Circulation. 2025;152:24-26.
    PubMed    
    
    
    
34. CUEVAS C, Kikushima-Alcantara P, Miranda JJ
    The State of Cardiovascular Care in Peru: Needs for System Strengthening.
    Circulation. 2025;152:7-10.
    PubMed    
    
    
    June 2025
35. GONG Y, Lu X, Wang X, Wang Y, et al
    Mitochondrial Tumor Suppressor 1A Attenuates Myocardial Infarction Injury by Maintaining the Coupling Between Mitochondria and Endoplasmic Reticulum.
    Circulation. 2025 Jun 30. doi: 10.1161/CIRCULATIONAHA.124.069737.
    PubMed     Abstract available
    
    
    
36. DUAN Z, Lin Z
    Response by Duan and Lin to Letter Regarding Article, "Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics".
    Circulation. 2025;151:e1093-e1094.
    PubMed    
    
    
    
37. THRANE PG, Maeng M, Maehara A, Botker HE, et al
    Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy.
    Circulation. 2025;151:1767-1779.
    PubMed     Abstract available
    
    
    
38. WANG H, Zhao T, Zheng G
    Letter by Wang et al Regarding Article, "Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics".
    Circulation. 2025;151:e1091-e1092.
    PubMed    
    
    
    
39. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
    Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2025;151:e1098.
    PubMed    
    
    
    
40. BELLAVIA A, Murphy SA
    Confounders, Effect Modifiers, and Mediators: Dealing With "Third Variables" in Cardiovascular Epidemiology.
    Circulation. 2025;151:1755-1757.
    PubMed    
    
    
    
41. JOHNY E, Dutta P
    Targeting Extramedullary Hematopoiesis and Cardiac Immune Homing to Encourage Cardiac Healing After Myocardial Infarction.
    Circulation. 2025;151:1748-1751.
    PubMed    
    
    
    
42. ARNAOUT R
    From Bytes to Beats: Overcoming Conceptual and Implementation Challenges for AI in Cardiovascular Care.
    Circulation. 2025;151:1697-1698.
    PubMed    
    
    
    
43. CAMPO G, Pavasini R
    Response by Campo and Pavasini to Letter Regarding Article, "Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis".
    Circulation. 2025;151:e1049-e1050.
    PubMed    
    
    
    
44. PAN D, Wu W, Chen M
    Letter by Pan et al Regarding Article, "Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis".
    Circulation. 2025;151:e1047-e1048.
    PubMed    
    
    
    
45. PIANO MR, Marcus GM, Aycock DM, Buckman J, et al
    Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Jun 9. doi: 10.1161/CIR.0000000000001341.
    PubMed     Abstract available
    
    
    
46. LEE S, Hwang SH, Park S, Son Y, et al
    Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Binational Population-Based Cohort Study.
    Circulation. 2025 Jun 4. doi: 10.1161/CIRCULATIONAHA.125.073086.
    PubMed     Abstract available
    
    
    
47. OBEL LM, Skovbo JS, Diederichsen ACP, Thomassen M, et al
    Aortic Aneurysm Risk and Somatic JAK2(V617F)Variation: Insights From a Multicenter, Population-Based Cardiovascular Screening Study.
    Circulation. 2025 Jun 4. doi: 10.1161/CIRCULATIONAHA.125.074002.
    PubMed     Abstract available
    
    
    
48. CHU L, Wang R, Gross CP, Wei J, et al
    Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States.
    Circulation. 2025 Jun 3. doi: 10.1161/CIRCULATIONAHA.124.073614.
    PubMed     Abstract available
    
    
    
49. GREGSON J, Taylor D, Owen R, Collier T, et al
    Hierarchical Composite Outcomes and Win Ratio Methods in Cardiovascular Trials: A Review and Consequent Guidance.
    Circulation. 2025;151:1606-1619.
    PubMed     Abstract available
    
    
    May 2025
50. SCHNEEWEISS S, Kruger N
    Non-Randomized Database Analyses to Complement Randomized Clinical Trials: Promising Approaches for Cardiovascular Medicine.
    Circulation. 2025;151:1495-1497.
    PubMed    
    
    
    
51. BERRY C, McCartney P
    Letter by Berry and McCartney Regarding Article, "Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention (The PITRI Trial)".
    Circulation. 2025;151:e1002-e1003.
    PubMed    
    
    
    
52. BULLUCK H, Hausenloy DJ
    Response by Bulluck and Hausenloy to Letter Regarding Article, "Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (the PITRI Trial)".
    Circulation. 2025;151:e1004-e1005.
    PubMed    
    
    
    
53. BOHULA EA, Landzberg MJ, Menon V, Alviar CL, et al
    Palliative and End-of-Life Care During Critical Cardiovascular Illness: A Scientific Statement From the American Heart Association.
    Circulation. 2025 May 15. doi: 10.1161/CIR.0000000000001334.
    PubMed     Abstract available
    
    
    
54. ZHANG Z, Yang X, Zhang Z
    Letter by Zhang et al Regarding Article, "Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study".
    Circulation. 2025;151:e986-e987.
    PubMed    
    
    
    
55. REITAN C, Andell P, Hofmann R, Jernberg T, et al
    Response by Reitan et al to Letter Regarding Article, "Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study".
    Circulation. 2025;151:e988-e989.
    PubMed    
    
    
    
56. WHITAKER KM, Barone Gibbs B, Hivert MF, Makarem N, et al
    Correction to: Sedentary Behavior and Light-intensity Physical Activity During Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart Association.
    Circulation. 2025;151:e1000.
    PubMed    
    
    
    
57. SATTAR N, Weerakkody GJ, McGuire DK, Kosiborod MN, et al
    The Association Between Tirzepatide Versus Insulin Glargine and NT-proBNP Levels in People With Type 2 Diabetes With or at Elevated Risk for Cardiovascular Disease: Post hoc Analyses of SURPASS 4.
    Circulation. 2025;151:1430-1432.
    PubMed    
    
    
    April 2025
58. CLARKE R, Wright N, Lin K, Yu C, et al
    Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study.
    Circulation. 2025 Apr 29. doi: 10.1161/CIRCULATIONAHA.124.072086.
    PubMed     Abstract available
    
    
    
59. BROWN TM, Pack QR, Aberegg E, Brewer LC, et al
    Correction to: Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.
    Circulation. 2025;151:e965-e966.
    PubMed    
    
    
    
60. DONG J, Yang X, Zhang W
    Letter by Dong et al Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".
    Circulation. 2025;151:e962-e963.
    PubMed    
    
    
    
61. BONNESEN K, Heide-Jorgensen U, Schmidt M
    Response by Bonnesen et al to Letter Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".
    Circulation. 2025;151:e964.
    PubMed    
    
    
    
62. ISMAHIL MA, Zhou G, Rajasekar S, Gao M, et al
    Splenic CD169(+)Tim4(+) Marginal Metallophilic Macrophages Are Essential for Wound Healing After Myocardial Infarction.
    Circulation. 2025 Apr 28. doi: 10.1161/CIRCULATIONAHA.124.071772.
    PubMed     Abstract available
    
    
    
63. LV H, Wang C, Liu Z, Quan M, et al
    Suppression of the Prostaglandin I2-Type 1 Interferon Axis Induces Extramedullary Hematopoiesis to Promote Cardiac Repair After Myocardial Infarction.
    Circulation. 2025 Apr 28. doi: 10.1161/CIRCULATIONAHA.124.069420.
    PubMed     Abstract available
    
    
    
64. BERRY JD, Zabad N, Kyrouac D, Leonard D, et al
    High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study.
    Circulation. 2025 Apr 21. doi: 10.1161/CIRCULATIONAHA.124.070335.
    PubMed     Abstract available
    
    
    
65. GRAVEN LJ, Kitko L, Abshire Saylor M, Allen L, et al
    Palliative Care and Advanced Cardiovascular Disease in Adults: Not Just End-of-Life Care: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Apr 17. doi: 10.1161/CIR.0000000000001323.
    PubMed     Abstract available
    
    
    
66. STAMATAKIS E, Biswas RK, Koemel NA, Sabag A, et al
    Dose Response of Incidental Physical Activity Against Cardiovascular Events and Mortality.
    Circulation. 2025;151:1063-1075.
    PubMed     Abstract available
    
    
    
67. WHITAKER KM, Barone Gibbs B, Hivert MF, Makarem N, et al
    Sedentary Behavior and Light-Intensity Physical Activity During Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart Association.
    Circulation. 2025 Apr 10. doi: 10.1161/CIR.0000000000001316.
    PubMed     Abstract available
    
    
    
68. CHEN Q, Zheng A, Xu X, Shi Z, et al
    Nrf3-Mediated Mitochondrial Superoxide Promotes Cardiomyocyte Apoptosis and Impairs Cardiac Functions by Suppressing Pitx2.
    Circulation. 2025;151:1024-1046.
    PubMed     Abstract available
    
    
    
69. LAM NT, Nguyen NUN, Elhelaly WM, Hsu CC, et al
    Induced Cytokinesis Generates Highly Proliferative Mononuclear Cardiomyocytes at the Expense of Contractility.
    Circulation. 2025;151:1009-1023.
    PubMed     Abstract available
    
    
    
70. BENOWITZ NL
    Predicting Cardiovascular Risk With Use of Various Tobacco Products.
    Circulation. 2025;151:1006-1008.
    PubMed    
    
    
    
71. STEG PG, Szarek M, Jukema JW, Bhatt DL, et al
    Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of O
    Circulation. 2025;151:1047-1050.
    PubMed    
    
    
    
72. POWELL-WILEY TM, Brewer LC, Burke LE, Hernandez R, et al
    Role of Technology in Promoting Heart Healthy Behavior Change to Increase Equity in Optimal Cardiovascular Health: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Apr 7. doi: 10.1161/CIR.0000000000001314.
    PubMed     Abstract available
    
    
    
73. SITTICHOKKANANON A, Garfield V, Chiesa ST
    Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes.
    Circulation. 2025 Apr 4. doi: 10.1161/CIRCULATIONAHA.124.070632.
    PubMed     Abstract available
    
    
    
74. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
    Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2025;151:e865.
    PubMed    
    
    
    
75. KIM JH, Baggish AL, Levine BD, Ackerman MJ, et al
    Correction to: Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2025;151:e864.
    PubMed    
    
    
    
76. YU M, Cheng X
    Response by Yu and Cheng to Letter Regarding Article, "Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial".
    Circulation. 2025;151:e769-e770.
    PubMed    
    
    
    
77. KAKIZAKI R, Raber L
    Letter by Kakizaki and Raber Regarding Article, "Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial".
    Circulation. 2025;151:e767-e768.
    PubMed    
    
    
    March 2025
78. MARX N, Deanfield JE, Mann JFE, Arechavaleta R, et al
    Oral Semaglutide and Cardiovascular Outcomes in Persons With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial.
    Circulation. 2025 Mar 29. doi: 10.1161/CIRCULATIONAHA.125.074545.
    PubMed     Abstract available
    
    
    
79. BAIREY MERZ CN, Bonow RO, Carnethon M, Crea F, et al
    Role of Cardiovascular Disease Journals in Reporting Sex and Gender in Research.
    Circulation. 2025 Mar 28. doi: 10.1161/CIRCULATIONAHA.125.074517.
    PubMed    
    
    
    
80. RYAN TD, Bates JE, Kinahan KE, Leger KJ, et al
    Cardiovascular Toxicity in Patients Treated for Childhood Cancer: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Mar 19. doi: 10.1161/CIR.0000000000001308.
    PubMed     Abstract available
    
    
    
81. NDUMELE CE, Ferdinand KC, Khan SS
    The Role of Race in Cardiovascular Disease Risk Prediction.
    Circulation. 2025;151:741-743.
    PubMed    
    
    
    
82. HULL LE, Aday AW, Bui QM, Luzum JA, et al
    Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Mar 13. doi: 10.1161/CIR.0000000000001304.
    PubMed     Abstract available
    
    
    
83. KURAMITSU S, Kawase Y, Shinozaki T, Domei T, et al
    Prevalence and Clinical Outcomes of Discordant Lesions Between Fractional Flow Reserve and Nonhyperemic Pressure Ratios in Clinical Practice: The J-PRIDE Registry.
    Circulation. 2025;151:672-685.
    PubMed     Abstract available
    
    
    
84. PAPATHEODOROU E, Aengevaeren VL, Eijsvogels TMH, AlFakih K, et al
    Correction to: Prevalence of Coronary Atherosclerosis in Female Masters Endurance Athletes.
    Circulation. 2025;151:e709.
    PubMed    
    
    
    
85. CLAUDEL SE, Verma A
    Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review.
    Circulation. 2025;151:716-732.
    PubMed     Abstract available
    
    
    
86. ARUNOTHAYARAJ S, Egred M, Banning AP, Brunel P, et al
    Stepwise Provisional Versus Systematic Dual-Stent Strategies for Treatment of True Left Main Coronary Bifurcation Lesions.
    Circulation. 2025;151:612-622.
    PubMed     Abstract available
    
    
    
87. KOU S, Lu Z, Deng D, Ye M, et al
    Activation of Imprinted Gene PW1 Promotes Cardiac Fibrosis After Ischemic Injury.
    Circulation. 2025;151:623-639.
    PubMed     Abstract available
    
    
    February 2025
88. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
    2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2025 Feb 27. doi: 10.1161/CIR.0000000000001309.
    PubMed     Abstract available
    
    
    
89. 
    Correction to: Abstract 4139285: Awareness of Myocardial Infarction and Stroke Symptoms Among Asian American Adults: Insights from the National Health Interview Survey 2014 and 2017.
    Circulation. 2025;151:e681.
    PubMed    
    
    
    
90. 
    Correction to: Abstract 4139303: Temporal Trends in Cardiovascular Risk Factors and Cardiovascular Disease among Middle Eastern Immigrants in the National Health Interview Survey 2004-2018.
    Circulation. 2025;151:e680.
    PubMed    
    
    
    
91. STARK AW, Matthey-de-l'Endroit RL, Ferroni A, Kakizaki R, et al
    Coronary CT Anatomy-Based Prediction of Invasively Assessed Hemodynamic Significance in Middle-Aged Patients With Right Coronary Artery Anomaly: The NARCO Study.
    Circulation. 2025;151:578-580.
    PubMed    
    
    
    
92. KIM JH, Baggish AL, Levine BD, Ackerman MJ, et al
    Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2025 Feb 20. doi: 10.1161/CIR.0000000000001297.
    PubMed     Abstract available
    
    
    
93. ARMILLOTTA M, Bergamaschi L, Paolisso P, Belmonte M, et al
    Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non-ST-Segment-Elevation Myocardial Infarction.
    Circulation. 2025 Feb 19. doi: 10.1161/CIRCULATIONAHA.124.070729.
    PubMed     Abstract available
    
    
    
94. NELLIPUDI JA, Kelly B, Hardikar A
    Addressing Cardiovascular Health Inequities in Indigenous Women: Insights from Australia and Global Perspectives.
    Circulation. 2025;151:427-429.
    PubMed    
    
    
    
95. WINDFELD-MATHIASEN J, Heerfordt IM, Dalhoff KP, Traerup Andersen J, et al
    Cardiovascular Disease in Anabolic Androgenic Steroid Users.
    Circulation. 2025 Feb 13. doi: 10.1161/CIRCULATIONAHA.124.071117.
    PubMed     Abstract available
    
    
    
96. KIM SM, Kim S, Kim YJ, Kim WY, et al
    Major Adverse Cardiovascular Events 1 Year After Discharge in Out-of-Hospital Cardiac Arrest Survivors.
    Circulation. 2025;151:421-423.
    PubMed    
    
    
    
97. BRENNAN SO, Kelly PJ, Gorey S, Synnott P, et al
    Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization Study.
    Circulation. 2025;151:334-336.
    PubMed    
    
    
    January 2025
98. DAI J, Zhao J, Xu X, Chen Y, et al
    Long-Term Prognostic Implications of Non-Culprit Lesions in Patients Presenting With an Acute Myocardial Infarction: Is It the Angiographic Stenosis Severity or the Underlying High-Risk Morphology?
    Circulation. 2025 Jan 31. doi: 10.1161/CIRCULATIONAHA.124.071855.
    PubMed     Abstract available
    
    
    
99. HALL EJ, Agarwal S, Cullum CM, Sinha SS, et al
    Survivorship After Cardiogenic Shock.
    Circulation. 2025;151:257-271.
    PubMed     Abstract available
    
    
    
100. SINGER Z, Wijeysundera HC, Qiu F, Fang J, et al
     Driving Restrictions and Incapacitation Vulnerability Evaluation After ST-Segment-Elevation Myocardial Infarction: DRIVE-STEMI Study.
     Circulation. 2025;151:282-284.
     PubMed    
     
     
     
101. 
     Correction to: Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation.
     Circulation. 2025;151:e30.
     PubMed    
     
     
     
102. MAURICIO R, Sharma G, Lewey J, Tompkins R, et al
     Assessing and Addressing Cardiovascular and Obstetric Risks in Patients Undergoing Assisted Reproductive Technology: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Jan 15. doi: 10.1161/CIR.0000000000001292.
     PubMed     Abstract available
     
     
     
103. CHEN JZ, Liang Y, Liang B
     Letter by Chen et al Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction".
     Circulation. 2025;151:e22.
     PubMed    
     
     
     
104. SUN M, He S, Hu J, Zhang Y, et al
     Response by Sun et al to Letter Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction".
     Circulation. 2025;151:e23.
     PubMed    
     
     
     
105. SIDIQI AW, Dad Zada D, Exeer NA
     Global Rounds Afghanistan: A Critical Overview of Cardiovascular Medicine.
     Circulation. 2025;151:129-131.
     PubMed    
     
     
     
106. ROGNE T, Gill D
     Adverse Pregnancy Outcomes and Coronary Artery Disease Risk: A Negative Control Mendelian Randomization Study.
     Circulation. 2025;151:193-195.
     PubMed    
     
     
     
107. LIU S, Deshmukh V, Meng F, Wang Y, et al
     Microtubules Sequester Acetylated YAP in the Cytoplasm and Inhibit Heart Regeneration.
     Circulation. 2025;151:59-75.
     PubMed     Abstract available
     
     
     
108. CHEW NWS, Mehta A, Goh RSJ, Zhang A, et al
     Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach.
     Circulation. 2025;151:98-119.
     PubMed     Abstract available
     
     
     December 2024
109. TOMII D, Pilgrim T, Borger MA, De Backer O, et al
     Aortic Stenosis and Coronary Artery Disease: Decision-Making Between Surgical and Transcatheter Management.
     Circulation. 2024;150:2046-2069.
     PubMed     Abstract available
     
     
     
110. ZWECK E, Hassager C, Beske RP, Jensen LO, et al
     Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial.
     Circulation. 2024;150:1990-2003.
     PubMed     Abstract available
     
     
     
111. BIRKENFELD AL, Franks PW, Mohan V
     Precision Medicine in People at Risk for Diabetes and Atherosclerotic Cardiovascular Disease: A Fresh Perspective on Prevention.
     Circulation. 2024;150:1910-1912.
     PubMed    
     
     
     
112. LEWANDOWSKI AJ, Rutter MK, Collins R
     Scientific and Clinical Impacts of UK Biobank in Cardiovascular Medicine.
     Circulation. 2024;150:1907-1909.
     PubMed    
     
     
     
113. JONE PN, Tremoulet A, Choueiter N, Dominguez SR, et al
     Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2024;150:e481-e500.
     PubMed     Abstract available
     
     
     
114. DENNISON HIMMELFARB CR, Benowitz NL, Blank MD, Bhatnagar A, et al
     Impact of Smokeless Oral Nicotine Products on Cardiovascular Disease: Implications for Policy, Prevention, and Treatment: A Policy Statement From the American Heart Association.
     Circulation. 2024 Dec 3. doi: 10.1161/CIR.0000000000001293.
     PubMed     Abstract available
     
     
     
115. LINDNER JR, Morello M
     In Vivo Cardiovascular Molecular Imaging: Contributions to Precision Medicine and Drug Development.
     Circulation. 2024;150:1885-1897.
     PubMed     Abstract available
     
     
     
116. ARMBRUSTER S, Skali H, Wei LJ
     Pitfalls of Choosing a Study End Point Including Cardiovascular Death in Comparative Clinical Trials.
     Circulation. 2024;150:1823-1825.
     PubMed    
     
     
     November 2024
117. QIN D, Modanwal R, Kitsis RN
     Extracellular Role for the Intracellular Cell Death Mediator RIPK3 in Myocardial Infarction.
     Circulation. 2024;150:1812-1814.
     PubMed    
     
     
     
118. ZHANG W, Zhang J, Wang Z, Li T, et al
     Extracellular RIPK3 Acts as a Damage-Associated Molecular Pattern to Exaggerate Cardiac Ischemia/Reperfusion Injury.
     Circulation. 2024;150:1791-1811.
     PubMed     Abstract available
     
     
     
119. ITZHAKI BEN ZADOK O, Simitsis P, Jacobson C, Nadeem O, et al
     Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy.
     Circulation. 2024;150:1815-1817.
     PubMed    
     
     
     
120. JI Y, Zhang MJ, Wang W, Norby FL, et al
     Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS.
     Circulation. 2024 Nov 21. doi: 10.1161/CIRCULATIONAHA.124.070278.
     PubMed     Abstract available
     
     
     
121. MORROW A, Young R, Abraham GR, Hoole S, et al
     Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial.
     Circulation. 2024;150:1671-1683.
     PubMed     Abstract available
     
     
     
122. 
     Correction to: 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Gui
     Circulation. 2024;150:e466.
     PubMed    
     
     
     
123. GIUGNI FR, Berry JD, Khera A, Shah AM, et al
     Precision Medicine for Cardiovascular Prevention and Population Health: A Bridge Too Far?
     Circulation. 2024;150:1720-1731.
     PubMed     Abstract available
     
     
     
124. HO FK, Mark PB, Lees JS, Pell JP, et al
     A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia.
     Circulation. 2024 Nov 14. doi: 10.1161/CIRCULATIONAHA.124.070454.
     PubMed     Abstract available
     
     
     
125. GREIF R, Bray JE, Djarv T, Drennan IR, et al
     2024 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Educatio
     Circulation. 2024 Nov 14. doi: 10.1161/CIR.0000000000001288.
     PubMed     Abstract available
     
     
     
126. XU X, Zhu H, Xu K
     Letter by Xu et al Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
     Circulation. 2024;150:e444.
     PubMed    
     
     
     
127. LIANG Y, Liang B
     Letter by Y. Liang and B. Liang Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
     Circulation. 2024;150:e443.
     PubMed    
     
     
     
128. YAN Y, Nie S, Montalescot G
     Response by Yan et al to Letter Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
     Circulation. 2024;150:e445-e446.
     PubMed    
     
     
     
129. DEZFULIAN C, McCallin TE, Bierens J, Dunne CL, et al
     2024 American Heart Association and American Academy of Pediatrics Focused Update on Special Circumstances: Resuscitation Following Drowning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardio
     Circulation. 2024 Nov 12. doi: 10.1161/CIR.0000000000001274.
     PubMed     Abstract available
     
     
     
130. KIM Y, Landstrom AP, Shah SH, Wu JC, et al
     Gene Therapy in Cardiovascular Disease: Recent Advances and Future Directions in Science: A Science Advisory From the American Heart Association.
     Circulation. 2024 Nov 11. doi: 10.1161/CIR.0000000000001296.
     PubMed     Abstract available
     
     
     
131. MA C, Ge J, Han Y
     Global Rounds: Advancing Cardiovascular Health in China.
     Circulation. 2024 Nov 7. doi: 10.1161/CIRCULATIONAHA.124.071544.
     PubMed    
     
     
     
132. AVERBUCH T, Stelkia K, Van Spall HGC
     Cardiovascular Care in Canada: Strengths, Challenges, and Opportunities For Improvement.
     Circulation. 2024;150:1490-1492.
     PubMed    
     
     
     
133. BHATIA HS, Wandel S, Willeit P, Lesogor A, et al
     Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis.
     Circulation. 2024 Nov 4. doi: 10.1161/CIRCULATIONAHA.124.069556.
     PubMed     Abstract available
     
     
     
134. DILLON HT, Saner NJ, Ilsley T, Kliman DS, et al
     Preventing Allogeneic Stem Cell Transplant-Related Cardiovascular Dysfunction: ALLO-Active Trial.
     Circulation. 2024 Nov 4. doi: 10.1161/CIRCULATIONAHA.124.070709.
     PubMed     Abstract available
     
     
     October 2024
135. VAN DIEPEN S, Poss J, Senaratne JM, Gage A, et al
     Mixed Cardiogenic Shock: A Proposal for Standardized Classification, a Hemodynamic Definition, and Framework for Management.
     Circulation. 2024;150:1459-1468.
     PubMed     Abstract available
     
     
     
136. PAPATHEODOROU E, Aengevaeren VL, Eijsvogels TMH, AlFakih K, et al
     Prevalence of Coronary Atherosclerosis in Female Masters Endurance Athletes.
     Circulation. 2024;150:1478-1480.
     PubMed    
     
     
     
137. GRAGNANO F, van Klaveren D, Heg D, Raber L, et al
     Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention.
     Circulation. 2024 Oct 27. doi: 10.1161/CIRCULATIONAHA.124.072009.
     PubMed     Abstract available
     
     
     
138. FOLEY MJ, Rajkumar CA, Ahmed-Jushuf F, Simader F, et al
     Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease.
     Circulation. 2024 Oct 27. doi: 10.1161/CIRCULATIONAHA.124.072281.
     PubMed     Abstract available
     
     
     
139. SELLKE FW
     Bleeding After Cardiovascular Surgery: A Continuing Problem.
     Circulation. 2024;150:1324-1326.
     PubMed    
     
     
     
140. RUEL M, de Lemos J, Fischbein M, Hill JA, et al
     Introduction to the 2024 Cardiovascular Surgery-Themed Issue of Circulation.
     Circulation. 2024;150:1307.
     PubMed    
     
     
     
141. HOFMANN C, Serafin A, Schwerdt OM, Fischer J, et al
     Transient Inhibition of Translation Improves Cardiac Function After Ischemia/Reperfusion by Attenuating the Inflammatory Response.
     Circulation. 2024;150:1248-1267.
     PubMed     Abstract available
     
     
     
142. SILBERNAGEL G, Chen YQ, Li H, Lemen D, et al
     Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality.
     Circulation. 2024 Oct 11. doi: 10.1161/CIRCULATIONAHA.124.069272.
     PubMed     Abstract available
     
     
     
143. KRISTENSEN JH, Hasselbalch RB, Strandkjaer N, Jorgensen N, et al
     Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans.
     Circulation. 2024;150:1187-1198.
     PubMed     Abstract available
     
     
     
144. SINNAEVE PR, Welsh RC, Arias Mendoza A, Ristic AD, et al
     Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Elevation Myocardial Infarction: STREAM-2 1-Year Mortality Follow-Up.
     Circulation. 2024;150:1151-1153.
     PubMed    
     
     
     
145. RUEL M, Chikwe J
     Coronary Artery Bypass Grafting: Past and Future.
     Circulation. 2024;150:1067-1069.
     PubMed    
     
     
     
146. KNEUER JM, Grajek IA, Winkler M, Erbe S, et al
     Novel Long Noncoding RNA HEAT4 Affects Monocyte Subtypes, Reducing Inflammation and Promoting Vascular Healing.
     Circulation. 2024;150:1101-1120.
     PubMed     Abstract available
     
     
     September 2024
147. ZHAO X, Williamson T, Gong Y, Epstein JA, et al
     Immunomodulatory Therapy for Ischemic Heart Disease.
     Circulation. 2024;150:1050-1058.
     PubMed     Abstract available
     
     
     
148. DUAN Z, Huang Z, Lei W, Zhang K, et al
     Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics.
     Circulation. 2024 Sep 24. doi: 10.1161/CIRCULATIONAHA.123.065935.
     PubMed     Abstract available
     
     
     
149. GIACOPPO D, Laudani C, Occhipinti G, Spagnolo M, et al
     Response by Giacoppo et al to Letter Regarding Article "Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis".
     Circulation. 2024;150:e271-e272.
     PubMed    
     
     
     
150. ZHANG Z
     Letter by Zhang Regarding Article, "Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis".
     Circulation. 2024;150:e269-e270.
     PubMed    
     
     
     
151. KOTWAL SS, Perkovic V
     Kidney Disease as a Cardiovascular Disease Priority.
     Circulation. 2024;150:975-977.
     PubMed    
     
     
     
152. THOMPSON A, Fleischmann KE, Smilowitz NR, de Las Fuentes L, et al
     2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2024 Sep 24. doi: 10.1161/CIR.0000000000001285.
     PubMed     Abstract available
     
     
     
153. BROWN TM, Pack QR, Aberegg E, Brewer LC, et al
     Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.
     Circulation. 2024 Sep 24. doi: 10.1161/CIR.0000000000001289.
     PubMed     Abstract available
     
     
     
154. LEE DH
     Microplastics and Cardiovascular Diseases: Importance of Coexisting Environmental Pollutants.
     Circulation. 2024;150:908-910.
     PubMed    
     
     
     
155. SHAH NS, Kandula NR, Commodore-Mensah Y, Morey BN, et al
     Social Determinants of Cardiovascular Health in Asian Americans: A Scientific Statement From the American Heart Association.
     Circulation. 2024 Sep 16. doi: 10.1161/CIR.0000000000001278.
     PubMed     Abstract available
     
     
     
156. BUTALA NM, Bucholz EM
     Quantifying Longevity After Myocardial Infarction: What Is Lost and What Is Gained.
     Circulation. 2024;150:836-837.
     PubMed    
     
     
     
157. BEI Y, Zhu Y, Zhou J, Ai S, et al
     Inhibition of Hmbox1 Promotes Cardiomyocyte Survival and Glucose Metabolism Through Gck Activation in Ischemia/Reperfusion Injury.
     Circulation. 2024;150:848-866.
     PubMed     Abstract available
     
     
     
158. DIWAN A
     The Case for Restoring Organelles to Treat Ischemic Cardiomyopathy: Is DEPP1 an Attractive Target?
     Circulation. 2024;150:787-790.
     PubMed    
     
     
     
159. WYANT GA, Jiang Q, Singh M, Qayyum S, et al
     Induction of DEPP1 by HIF Mediates Multiple Hallmarks of Ischemic Cardiomyopathy.
     Circulation. 2024;150:770-786.
     PubMed     Abstract available
     
     
     
160. VOLPP KG
     Using Behavioral Science to Improve Cardiovascular Health.
     Circulation. 2024;150:743-745.
     PubMed    
     
     
     
161. SIMON T, Herbert BM, Brooks MM, Goodman SG, et al
     Restrictive or Liberal Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: 6-Month Mortality in the MINT Trial.
     Circulation. 2024 Sep 2. doi: 10.1161/CIRCULATIONAHA.124.069917.
     PubMed    
     
     
     
162. CAMPO G, Bohm F, Engstrom T, Smits PC, et al
     Complete vs. Culprit-Only Revascularization in Older Patients with ST-segment Elevation Myocardial Infarction: An Individual Patient Meta-Analysis.
     Circulation. 2024 Sep 1. doi: 10.1161/CIRCULATIONAHA.124.071493.
     PubMed     Abstract available
     
     
     August 2024
163. BODEN WE, De Caterina R, Kaski JC, Bairey Merz CN, et al
     Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice Guidelines.
     Circulation. 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.123.065656.
     PubMed     Abstract available
     
     
     
164. NEUEN BL, Fletcher RA, Heath L, Perkovic A, et al
     Cardiovascular, Kidney and Safety Outcomes with GLP-1 Receptor Agonists Alone and in Combination with SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis.
     Circulation. 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.124.071689.
     PubMed     Abstract available
     
     
     
165. DEFILIPPIS AP, Abbott JD, Herbert BM, Bertolet MH, et al
     Restrictive Versus Liberal Transfusion in Patients with Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the Myocardial Ischemia and Transfusion (MINT) Trial.
     Circulation. 2024 Aug 29. doi: 10.1161/CIRCULATIONAHA.124.071208.
     PubMed     Abstract available
     
     
     
166. BONNESEN K, Heide-Jorgensen U, Christensen DH, Lash TL, et al
     Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation.
     Circulation. 2024 Aug 29. doi: 10.1161/CIRCULATIONAHA.124.068613.
     PubMed     Abstract available
     
     
     
167. DELWARDE C, Aikawa M
     Novel Mouse Model of Late-Stage Coronary Atherosclerosis With Features of Plaque Rupture and Stroke.
     Circulation. 2024;150:706-709.
     PubMed    
     
     
     
168. LI J, Sun S, Zhu D, Mei X, et al
     Inhalable Stem Cell Exosomes Promote Heart Repair After Myocardial Infarction.
     Circulation. 2024;150:710-723.
     PubMed     Abstract available
     
     
     
169. YU M, Yang Y, Dong SL, Zhao C, et al
     Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial.
     Circulation. 2024 Aug 21. doi: 10.1161/CIRCULATIONAHA.124.069808.
     PubMed     Abstract available
     
     
     
170. KERN MJ, Seto AH
     Does PPG, the Other Dimension to FFR, Better Predict Post-PCI Results?
     Circulation. 2024;150:598-599.
     PubMed    
     
     
     
171. KOBAYASHI H, Tohyama S, Ichimura H, Ohashi N, et al
     Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.
     Circulation. 2024;150:611-621.
     PubMed     Abstract available
     
     
     
172. KOVILAKATH A, Mauro AG, Valentine YA, Raucci FJ, et al
     SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy.
     Circulation. 2024;150:622-641.
     PubMed     Abstract available
     
     
     
173. ABBATE A, Van Tassell B, Bogin V, Markley R, et al
     Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment-Elevation Myocardial Infarction (STEMI).
     Circulation. 2024;150:580-582.
     PubMed    
     
     
     
174. MOSLEHI JJ
     Cardio-Oncology: A New Clinical Frontier and Novel Platform for Cardiovascular Investigation.
     Circulation. 2024;150:513-515.
     PubMed     Abstract available
     
     
     
175. MORRIS SA, Flyer JN, Yetman AT, Quezada E, et al
     Cardiovascular Management of Aortopathy in Children: A Scientific Statement From the American Heart Association.
     Circulation. 2024 Aug 12. doi: 10.1161/CIR.0000000000001265.
     PubMed     Abstract available
     
     
     
176. LIN Y, Gil CH, Banno K, Yokoyama M, et al
     ABCG2-Expressing Clonal Repopulating Endothelial Cells Serve to Form and Maintain Blood Vessels.
     Circulation. 2024;150:451-465.
     PubMed     Abstract available
     
     
     
177. BITTNER V
     Eicosapentanoic Acid Supplementation for Atherosclerotic Cardiovascular Disease Prevention.
     Circulation. 2024;150:435-438.
     PubMed    
     
     
     
178. JOYNT MADDOX KE
     Health Economics of Cardiovascular Disease in the United States.
     Circulation. 2024;150:419-421.
     PubMed    
     
     
     
179. MARTINEZ-MORATA I, Schilling K, Glabonjat RA, Domingo-Relloso A, et al
     Association of Urinary Metals With Cardiovascular Disease Incidence and All-Cause Mortality in the Multi-Ethnic Study of Atherosclerosis (MESA).
     Circulation. 2024 Aug 1. doi: 10.1161/CIRCULATIONAHA.124.069414.
     PubMed     Abstract available
     
     
     July 2024
180. 
     Correction to: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2024;150:e105.
     PubMed    
     
     
     
181. VALGIMIGLI M, Landi A, Angiolillo DJ, Baber U, et al
     Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome.
     Circulation. 2024;150:317-335.
     PubMed     Abstract available
     
     
     
182. ARMSTRONG PW
     Global Collaborative Cardiovascular Research: The Collective Wisdom of Countries.
     Circulation. 2024;150:258-260.
     PubMed    
     
     
     
183. GRANT JK, Martin SS, Zhang S, Matsushita K, et al
     Racial Differences in the Burden of Atherosclerotic Cardiovascular Disease Related to Elevated Lipoprotein(a) Levels: The ARIC Study.
     Circulation. 2024;150:250-252.
     PubMed    
     
     
     
184. WANG Y, Chen GC, Wang Z, Luo K, et al
     Dietary Acculturation Is Associated With Altered Gut Microbiome, Circulating Metabolites, and Cardiovascular Disease Risk in US Hispanics and Latinos: Results From HCHS/SOL.
     Circulation. 2024;150:215-229.
     PubMed     Abstract available
     
     
     
185. SONG N, Beyene TJ, Amponsah DK, Asch SM, et al
     Novel Use of Z Codes to Identify Social Determinants of Cardiovascular Disease Outcomes.
     Circulation. 2024;150:243-245.
     PubMed    
     
     
     
186. ADEDINSEWO D
     Advancing Cardiovascular Health Equity With Artificial Intelligence: A Collective Ethical Responsibility.
     Circulation. 2024;150:174-176.
     PubMed    
     
     
     
187. WEYRICH M, Cremer S, Gerster M, Sarakpi T, et al
     Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease.
     Circulation. 2024 Jul 15. doi: 10.1161/CIRCULATIONAHA.124.069139.
     PubMed     Abstract available
     
     
     
188. ABBARA S, Shaw LJ
     Past, Present, and Future of CTA.
     Circulation. 2024;150:87-90.
     PubMed    
     
     
     
189. FLEG JL, Huang Z, Reynolds HR, Shaw LJ, et al
     Ischemia Severity, Coronary Artery Disease Extent, and Exercise Capacity in ISCHEMIA.
     Circulation. 2024;150:165-167.
     PubMed    
     
     
     
190. KUEHN BM
     Million Hearts Model Reduces Cardiovascular Events Without Increasing Care Costs.
     Circulation. 2024;150:162-164.
     PubMed    
     
     
     
191. REITAN C, Andell P, Alfredsson J, Erlinge D, et al
     Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study.
     Circulation. 2024 Jul 5. doi: 10.1161/CIRCULATIONAHA.124.068739.
     PubMed     Abstract available
     
     
     
192. BERRY C, Sidik NP, McEntegart MB
     Response by Berry et al to Letter Regarding Article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial".
     Circulation. 2024;150:e5-e6.
     PubMed    
     
     
     
193. NISHI T, Saito Y, Kobayashi Y
     Letter by Nishi et al Regarding Article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial".
     Circulation. 2024;150:e3-e4.
     PubMed    
     
     
     June 2024
194. KIM K, Joyce BT, Zheng Y, Nannini DR, et al
     Associations of Urban Blue and Green Spaces With Coronary Artery Calcification in Black Individuals and Disadvantaged Neighborhoods.
     Circulation. 2024 Jun 27. doi: 10.1161/CIRCULATIONAHA.123.067992.
     PubMed     Abstract available
     
     
     
195. TANNU M, Kaltenbach L, Pagidipati NJ, McGuire DK, et al
     Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes Trial.
     Circulation. 2024 Jun 27. doi: 10.1161/CIRCULATIONAHA.124.068962.
     PubMed     Abstract available
     
     
     
196. LIU T, Hao Y, Zhang Z, Zhou H, et al
     Advanced Cardiac Patches for the Treatment of Myocardial Infarction.
     Circulation. 2024;149:2002-2020.
     PubMed     Abstract available
     
     
     
197. JHA AK
     Letter by Jha Regarding Article, "Early Left Ventricular Unloading or Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: The EARLY-UNLOAD Randomized Clinical Trial".
     Circulation. 2024;149:e1415-e1416.
     PubMed    
     
     
     
198. ZHANG S, Zhang Y, Duan X, Wang B, et al
     Targeting NPM1 Epigenetically Promotes Postinfarction Cardiac Repair by Reprogramming Reparative Macrophage Metabolism.
     Circulation. 2024;149:1982-2001.
     PubMed     Abstract available
     
     
     
199. SHAMSUZZAMAN S, Deaton RA, Salamon A, Doviak H, et al
     Novel Mouse Model of Myocardial Infarction, Plaque Rupture, and Stroke Shows Improved Survival With Myeloperoxidase Inhibition.
     Circulation. 2024 Jun 17. doi: 10.1161/CIRCULATIONAHA.123.067931.
     PubMed     Abstract available
     
     
     
200. MIYAUCHI K, Iwata H, Nishizaki Y, Inoue T, et al
     Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid (RESPECT-EPA).
     Circulation. 2024 Jun 14. doi: 10.1161/CIRCULATIONAHA.123.065520.
     PubMed     Abstract available
     
     
     
201. 
     Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
     Circulation. 2024;149:e1411.
     PubMed    
     
     
     
202. HUNDLEY WG
     Fifty Years of Cardiovascular Magnetic Resonance: Continuing Evolution Toward the "One-Stop Shop" for Cardiovascular Diagnosis.
     Circulation. 2024;149:1859-1861.
     PubMed    
     
     
     
203. ANDREOTTI F, Burzotta F, Maggioni AP
     Letter by Andreotti et al Regarding Article, "Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance".
     Circulation. 2024;149:e1312.
     PubMed    
     
     
     
204. GURAGAIN B, Wei Y, Zhang H, Kahn-Krell A, et al
     Implanted Human Cardiac Spheroids Electrically Couple With Infarcted Swine Myocardium.
     Circulation. 2024;149:1855-1857.
     PubMed    
     
     
     
205. KAZI DS, Elkind MSV, Deutsch A, Dowd WN, et al
     Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association.
     Circulation. 2024 Jun 4. doi: 10.1161/CIR.0000000000001258.
     PubMed     Abstract available
     
     
     
206. MORAN AE, Goldman L
     Predicting the Future Prevalence of Cardiovascular Disease: The Good, the Bad, the Known, and the Unknown.
     Circulation. 2024 Jun 4. doi: 10.1161/CIRCULATIONAHA.124.070265.
     PubMed    
     
     
     
207. JOYNT MADDOX KE, Elkind MSV, Aparicio HJ, Commodore-Mensah Y, et al
     Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050-Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association.
     Circulation. 2024 Jun 4. doi: 10.1161/CIR.0000000000001256.
     PubMed     Abstract available
     
     
     May 2024
208. MEHTA LS, Churchwell K, Coleman D, Davidson J, et al
     Fostering Psychological Safety and Supporting Mental Health Among Cardiovascular Health Care Workers: A Science Advisory From the American Heart Association.
     Circulation. 2024 May 30. doi: 10.1161/CIR.0000000000001259.
     PubMed     Abstract available
     
     
     
209. NAKAMORI S, Amyar A, Fahmy AS, Ngo LH, et al
     Cardiovascular Magnetic Resonance Radiomics to Identify Components of the Extracellular Matrix in Dilated Cardiomyopathy.
     Circulation. 2024 May 29. doi: 10.1161/CIRCULATIONAHA.123.067107.
     PubMed     Abstract available
     
     
     
210. CALLER T, Rotem I, Shaihov-Teper O, Lendengolts D, et al
     Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth.
     Circulation. 2024;149:1729-1748.
     PubMed     Abstract available
     
     
     
211. ZHAI X, Cao S, Wang J, Qiao B, et al
     Carbonylation of Runx2 at K176 by 4-Hydroxynonenal Accelerates Vascular Calcification.
     Circulation. 2024;149:1752-1769.
     PubMed     Abstract available
     
     
     
212. 
     Correction to: 2022 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
     Circulation. 2024;149:e1218.
     PubMed    
     
     
     
213. SATTAR N, Neeland IJ, McGuire DK
     Obesity and Cardiovascular Disease: A New Dawn.
     Circulation. 2024;149:1621-1623.
     PubMed    
     
     
     
214. ZHU Q, Scherer PE
     Ceramides and Atherosclerotic Cardiovascular Disease: A Current Perspective.
     Circulation. 2024;149:1624-1626.
     PubMed    
     
     
     
215. BULLUCK H, Chong JH, Bryant J, Annathurai A, et al
     Effect of Cangrelor on Infarct Size in ST-Segment Elevation Myocardial Infarction Treated By Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (The PITRI Trial).
     Circulation. 2024 May 14. doi: 10.1161/CIRCULATIONAHA.124.068938.
     PubMed     Abstract available
     
     
     
216. COLLET C, Munhoz D, Mizukami T, Sonck J, et al
     Influence of Pathophysiological Patterns of Coronary Artery Disease on Immediate Percutaneous Coronary Intervention Outcomes.
     Circulation. 2024 May 14. doi: 10.1161/CIRCULATIONAHA.124.069450.
     PubMed     Abstract available
     
     
     
217. 
     Correction to: An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial.
     Circulation. 2024;149:e1189-e1190.
     PubMed    
     
     
     
218. TANG WHW, Hazen SL
     Unraveling the Complex Relationship Between Gut Microbiome and Cardiovascular Diseases.
     Circulation. 2024;149:1543-1545.
     PubMed    
     
     
     
219. MORRISON JT, Canonico ME, Anand SS, Patel MR, et al
     Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.
     Circulation. 2024;149:1536-1539.
     PubMed    
     
     
     April 2024
220. KELHAM M, Mathur A, Jones DA
     Response by Kelham et al to Letter Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial".
     Circulation. 2024;149:e1133.
     PubMed    
     
     
     
221. APOSTOLOS A, Karamasis GV, Tsigkas G
     Letter by Apostolos et al Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial".
     Circulation. 2024;149:e1132.
     PubMed    
     
     
     
222. ZAMAN S, Edwards NC, Chew DP
     Global Rounds: Cardiovascular Care in Australia and New Zealand.
     Circulation. 2024;149:1402-1404.
     PubMed    
     
     
     
223. SOLOMON CG, Landrigan PJ
     Fossil Fuels, Climate Change, and Cardiovascular Disease: A Call to Action.
     Circulation. 2024;149:1400-1401.
     PubMed    
     
     
     
224. LEMESLE G, Lamblin N, Schurtz G, Labreuche J, et al
     Comparison of Incidence and Prognostic Impact of Ischemic Major Bleeding and Heart Failure Events in Patients With Chronic Coronary Syndrome: Insights From the CORONOR Registry.
     Circulation. 2024 Apr 25. doi: 10.1161/CIRCULATIONAHA.123.067938.
     PubMed     Abstract available
     
     
     
225. GIRI J, Kaneko T
     Much Ado About Nothing? CABG or PCI for Left Main Coronary Artery Disease.
     Circulation. 2024;149:1339-1340.
     PubMed    
     
     
     
226. SHAH SH, Gerszten RE
     Sifting for Gold in Terabytes of Data: Illuminating Cardiovascular Biology in the 'Omics Age.
     Circulation. 2024;149:1323-1325.
     PubMed    
     
     
     
227. SWAIN L, Bhave S, Qiao X, Reyelt L, et al
     Novel Role for Cardiolipin as a Target of Therapy to Mitigate Myocardial Injury Caused by Venoarterial Extracorporeal Membrane Oxygenation.
     Circulation. 2024;149:1341-1353.
     PubMed     Abstract available
     
     
     
228. 
     Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
     Circulation. 2024;149:e1128.
     PubMed    
     
     
     
229. GOLDFARB MJ, Saylor MA, Bozkurt B, Code J, et al
     Patient-Centered Adult Cardiovascular Care: A Scientific Statement From the American Heart Association.
     Circulation. 2024 Apr 11. doi: 10.1161/CIR.0000000000001233.
     PubMed     Abstract available
     
     
     
230. PATEL SM, Kang YM, Im K, Neuen BL, et al
     Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
     Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069568.
     PubMed     Abstract available
     
     
     
231. FANAROFF AC, Patel MS, Chokshi N, Coratti S, et al
     Effect of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial.
     Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069531.
     PubMed     Abstract available
     
     
     
232. HERNANDEZ AF, Udell JA, Jones WS, Anker SD, et al
     Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial.
     Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.124.069217.
     PubMed     Abstract available
     
     
     
233. CHO L, Plutzky J, Brennan D, Louie MJ, et al
     Impact of Bempedoic Acid on Cardiovascular Outcomes by Sex.
     Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.123.067691.
     PubMed    
     
     
     
234. MAEHARA A, Sugizaki Y
     Intravascular Imaging for Guiding Percutaneous Coronary Intervention: What Does the Totality of Data Suggest, and Where Should We Go?
     Circulation. 2024;149:1087-1089.
     PubMed    
     
     
     
235. BLUMER V, Kanwar MK, Barnett CF, Cowger JA, et al
     Cardiogenic Shock in Older Adults: A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association.
     Circulation. 2024;149:e1051-e1065.
     PubMed     Abstract available
     
     
     
236. WU JC, Wilson BH, Fang JC, Hurwitz JL, et al
     Modernizing Cardiovascular Medicine Board Certification: Leveraging Innovation and Strengthening Continuous Competency and Professional Growth.
     Circulation. 2024 Apr 1. doi: 10.1161/CIRCULATIONAHA.124.069553.
     PubMed    
     
     
     March 2024
237. BERG-HANSEN K, Gopalasingam N, Christensen KH, Ladefoged B, et al
     Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial.
     Circulation. 2024 Mar 27. doi: 10.1161/CIRCULATIONAHA.123.067971.
     PubMed     Abstract available
     
     
     
238. LUSEBRINK E, Binzenhofer L, Hering D, Villegas Sierra L, et al
     Scrutinizing the Role of Venoarterial Extracorporeal Membrane Oxygenation: Has Clinical Practice Outpaced the Evidence?
     Circulation. 2024;149:1033-1052.
     PubMed     Abstract available
     
     
     
239. SERRUYS PW, Revaiah PC
     The American Heart Association's Centennial and Percutaneous Coronary Intervention's Semi-Centennial.
     Circulation. 2024;149:973-978.
     PubMed    
     
     
     
240. FENG J, Li Y, Li Y, Yin Q, et al
     Versican Promotes Cardiomyocyte Proliferation and Cardiac Repair.
     Circulation. 2024;149:1004-1015.
     PubMed     Abstract available
     
     
     
241. 
     Correction to: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.
     Circulation. 2024;149:e1023.
     PubMed    
     
     
     
242. SHUEY MM, Wang Y, Xiang RR, Zou A, et al
     Aggregation and Contextualization of Murine Investigations Improves Discovery of Significant Human Atherosclerotic Cardiovascular Disease Associations.
     Circulation. 2024;149:1056-1058.
     PubMed    
     
     
     
243. TENG Z, Ma Y, Ma X
     Letter by Teng et al Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction".
     Circulation. 2024;149:e960-e961.
     PubMed    
     
     
     
244. FRANGOGIANNIS NG
     Response by Frangogiannis to Letter Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction".
     Circulation. 2024;149:e962-e963.
     PubMed    
     
     
     
245. MARANO P, Mouapi K, Kim A, Mastali M, et al
     Apolipoproteins Quantified Using Blood Volumetric Absorptive Microsampling and High-Throughput Mass Spectrometry for Risk Assessment in Ischemic Heart Disease.
     Circulation. 2024;149:970-972.
     PubMed    
     
     
     
246. EVERETT BM
     The Confusing Landscape of Cardiovascular Health Assessment, Promotion, and Prediction.
     Circulation. 2024;149:914-916.
     PubMed    
     
     
     
247. LANDSTROM AP, Chahal CAA, Roden DM, Ho CY, et al
     A Customizable and Peer-Reviewed Curriculum for Cardiovascular Genetics and Genomics.
     Circulation. 2024;149:902-904.
     PubMed    
     
     
     
248. JUNCA G, Delgado V
     Dual (Ischemic and Nonischemic) Cardiomyopathy: A Wolf in Sheep's Clothing.
     Circulation. 2024;149:822-824.
     PubMed    
     
     
     
249. HEUTS S, Myers PO, Siepe M
     Letter by Heuts et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
     Circulation. 2024;149:892-893.
     PubMed    
     
     
     
250. RODRIGUEZ AE, Fernandez-Pereira C, Mieres J
     Letter by Rodriguez et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
     Circulation. 2024;149:894-895.
     PubMed    
     
     
     
251. ZIMMERMANN FM, Ding VY, Fearon WF
     Response by Zimmermann et al to Letter Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
     Circulation. 2024;149:896.
     PubMed    
     
     
     
252. HAYEK SS, Zaha VG, Bogle C, Deswal A, et al
     Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association.
     Circulation. 2024 Mar 11. doi: 10.1161/CIR.0000000000001220.
     PubMed     Abstract available
     
     
     
253. GABA P, Sabik JF, Murphy SA, Bellavia A, et al
     Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials.
     Circulation. 2024 Mar 11. doi: 10.1161/CIRCULATIONAHA.123.065571.
     PubMed     Abstract available
     
     
     
254. ALEXANDER T, Kumbhani DJ, Mullasari Sankardas A
     The Future of Pharmacoinvasive Therapy for ST-Segment-Elevation Myocardial Infarction Reperfusion in the Post-STREAM Era.
     Circulation. 2024;149:732-733.
     PubMed    
     
     
     
255. RAJAGOPALAN S, Brook RD
     Cardiovascular and Planetary Health: Two Sides of the Same Planet.
     Circulation. 2024;149:729-731.
     PubMed    
     
     
     February 2024
256. CHEN Z, Zhang J, He Y
     Letter by Chen et al Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
     Circulation. 2024;149:725-726.
     PubMed    
     
     
     
257. VAN DE WERF F, Sinnaeve P, Welsh RC, Armstrong PW, et al
     Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
     Circulation. 2024;149:727-728.
     PubMed    
     
     
     
258. GAFFEY AE, Rollman BL, Burg MM
     Strengthening the Pillars of Cardiovascular Health: Psychological Health is a Crucial Component.
     Circulation. 2024;149:641-643.
     PubMed    
     
     
     
259. DZAU VJ, Hodgkinson CP
     RNA Therapeutics for the Cardiovascular System.
     Circulation. 2024;149:707-716.
     PubMed     Abstract available
     
     
     
260. YAN Y, Guo J, Wang X, Wang G, et al
     Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial.
     Circulation. 2024 Feb 26. doi: 10.1161/CIRCULATIONAHA.123.067079.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.